thiazoles has been researched along with bmn 673 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, P; Ding, D; Gu, J; Jiang, N; Li, S; Lin, L; Lv, Y; Ma, X; Wang, Y; Xiao, X; Zhong, L | 1 |
1 other study(ies) available for thiazoles and bmn 673
Article | Year |
---|---|
PI3K p110α inhibition sensitizes cervical cancer cells with aberrant PI3K signaling activation to PARP inhibitor BMN673.
Topics: Cell Line, Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Middle Aged; Phosphatidylinositol 3-Kinases; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors; Signal Transduction; Thiazoles; Uterine Cervical Neoplasms | 2019 |